Combined Phacotrabeculectomy
Showing 1 - 25 of >10,000
Glaucoma, Angle-Closure Trial in Guangzhou, Guangdong (phacoemulsification with intraocular lens implantation combined with
Active, not recruiting
- Glaucoma, Angle-Closure
- phacoemulsification with intraocular lens implantation combined with goniosynechialysis and goniotomy
- phacoemulsification with intraocular lens implantation combined with trabeculectomy
-
Guangzhou, Guangdong, China
- +1 more
Aug 1, 2022
Glaucoma, Ocular Hypertension, Filtering Surgery Trial (phacotrabeculectomy, ExPress antiglaucoma surgery combined with
Completed
- Glaucoma
- +2 more
- phacotrabeculectomy
- ExPress antiglaucoma surgery combined with phacoemulsification
- (no location specified)
Apr 3, 2020
Ophthalmopathy, Glaucoma, Glaucoma, Angle-Closure Trial in Assiut (Phacoemulsification combined with trabeculectomy,
Completed
- Ophthalmopathy
- +2 more
- Phacoemulsification combined with trabeculectomy
- Phacoemulsificaiton combined with ab-externo trabeculotomy
-
Assiut, EgyptAssiut University Hospital
Oct 28, 2021
Non-small-cell Lung Cancer Trial in China (TQB2450 +Anlotinib+Docetaxel, TQB2450 +Androtinib Placebo+Docetaxel)
Recruiting
- Non-small-cell Lung Cancer
- TQB2450 +Anlotinib+Docetaxel
- TQB2450 +Androtinib Placebo+Docetaxel
-
Huizhou, Guangdong, China
- +4 more
Nov 15, 2023
Spinal for Caesarean Section Trial (prilocaine, bupivacaine)
Not yet recruiting
- Spinal for Caesarean Section
- (no location specified)
Nov 14, 2023
Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)
Recruiting
- Extensive Small Cell Lung Cancer
- Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
-
Jinan, Shan Dong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023
Combined Hepatocellular Cholangiocarcinoma Trial (gemcitabine ,oxaliplatin,anlotinib,Sintilimab)
Not yet recruiting
- Combined Hepatocellular Cholangiocarcinoma
- gemcitabine ,oxaliplatin,anlotinib,Sintilimab
- (no location specified)
Sep 10, 2023
Colorectal Cancer Trial in Tai'an (Tas-102(Suyuan) combined with bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Tas-102(Suyuan) combined with bevacizumab
-
Tai'an, Shandong, ChinaThe Second Affiliated Hospital of Shandong First Medical Univers
Oct 14, 2023
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
Exotropia, Evaluation of Surgical Techniques in Correcting Exotropia Trial (Evaluation of The Techniques of Lateral Rectus
Not yet recruiting
- Exotropia
- Evaluation of Surgical Techniques in Correcting Exotropia
- Evaluation of The Techniques of Lateral Rectus Muscle Combined Recession with Hang Back and Combined Recession with Z-Tenotomy in Correcting Large-Angle Exotropia
- (no location specified)
Oct 9, 2023
A Population-based, Multicenter Cohort Study of Combined
Not yet recruiting
- Digestive Disease
- Gastroenteroscopy；Risk factor investigation; FIT-HP;RNF180 and SEPTIN9 gene methylation test
- Risk factor investigation;
- (no location specified)
Aug 10, 2023
Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- Cadonilimab
- Stereotactic body radiotherapy
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Jun 20, 2023
Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)
Recruiting
- Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
-
Shanghai, Shanghai, ChinaThe Obstetrics & Gynecology Hospital of Fudan University (Shangh
Nov 3, 2023
Physiotherapy, Rotator Cuff Syndrome, Rotator Cuff Impingement Syndrome Trial (The COMBINED approach)
Not yet recruiting
- Physiotherapy
- +2 more
- The COMBINED approach
- (no location specified)
Apr 24, 2023
Post-Traumatic Scar Trial (subcision ,PRP or saline and microneedling)
Not yet recruiting
- Post-Traumatic Scar
- subcision ,PRP or saline and microneedling
- (no location specified)
Nov 12, 2023
Small Cell Lung Cancer Trial in Fuzhou (Surufatinib,Serplulimab,Etoposide,Carboplatin)
Not yet recruiting
- Small Cell Lung Cancer
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
May 20, 2023
Female Patients With Overactive Bladder Syndrome Trial in Banqiao (tolterodine, mirabegron, tolterodine , mirabegron)
Not yet recruiting
- Female Patients With Overactive Bladder Syndrome
- tolterodine
- +2 more
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jul 13, 2023
Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)
Recruiting
- Peripheral T Cell Lymphoma
- Epigenetic Repression
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 14, 2023
Imatinib With Hepatic Resection or Other Local Treatment for
Completed
- GIST, Malignant
- Liver Metastases
- imatinib (IM)
- +3 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Sep 12, 2023
Advanced Solid Tumor Trial (Adebrelimab, SHR-1802, Carboplatin/Cisplatin)
Not yet recruiting
- Advanced Solid Tumor
- Adebrelimab
- +3 more
- (no location specified)
Mar 20, 2023
HER2-expressing Advanced Solid Tumors Trial (SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor
Not yet recruiting
- HER2-expressing Advanced Solid Tumors
- SHR-A1811 combined with Pyrotinib.
- SHR-A1811 combined with other antitumor therapies
- (no location specified)
Aug 28, 2023
Locally Advanced or Metastatic NSCLC Trial in China (AK104, Tislelizumab, carboplatin)
Not yet recruiting
- Locally Advanced or Metastatic NSCLC
- AK104
- +4 more
-
Bengbu, Anhui, China
- +61 more
Aug 10, 2023
Skin Aging Trial (SkinCeuticals A.G.E, standard cream)
Not yet recruiting
- Skin Aging
- SkinCeuticals A.G.E
- standard cream
- (no location specified)
Feb 19, 2023